MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

Search

NeoGenomics Inc

Open

7.56 -24.93

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.56

Max

10.07

Schlüsselkennzahlen

By Trading Economics

Einkommen

2.4M

-15M

Verkäufe

4.2M

172M

EPS

0.04

Gewinnspanne

-8.909

Angestellte

2,200

EBITDA

1.9M

3.7M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+68.3% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

29. Apr. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-360M

1.2B

Vorheriger Eröffnungskurs

32.49

Vorheriger Schlusskurs

7.56

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

NeoGenomics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Apr. 2025, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Cantor Agrees to $3.6 Billion SPAC Deal With Crypto Company Twenty One -- Update

23. Apr. 2025, 14:29 UTC

Akquisitionen, Fusionen, Übernahmen

Cantor Agrees to $3.6 Billion SPAC Deal With Crypto Company Twenty One

16. Apr. 2025, 15:17 UTC

Wichtige Markttreiber

Janover Shares Drop After Partnership Plans With Crypto Exchange

28. Apr. 2025, 15:55 UTC

Akquisitionen, Fusionen, Übernahmen

MicroStrategy Buys Even More Bitcoin, Bringing Holdings Above 550,000 Tokens -- Barrons.com

28. Apr. 2025, 10:14 UTC

Market Talk

Bitcoin Lifted by Hopes For Easing Geopolitical Tensions -- Market Talk

26. Apr. 2025, 15:00 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

25. Apr. 2025, 11:31 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25. Apr. 2025, 11:31 UTC

Market Talk

Bitcoin Edges Higher as Risk Appetite Lifted by Optimism Over Trade Talks -- Market Talk

24. Apr. 2025, 11:49 UTC

Market Talk

Bitcoin Eases After Recent Risk-On Rally -- Market Talk

23. Apr. 2025, 15:35 UTC

Akquisitionen, Fusionen, Übernahmen

Cantor Agrees to $3.6B SPAC Deal With Crypto Company Twenty One -- Update

23. Apr. 2025, 14:14 UTC

Akquisitionen, Fusionen, Übernahmen

Cantor Agrees to $3.6B SPAC Deal With Crypto Company Twenty One

23. Apr. 2025, 09:17 UTC

Top News

Bitcoin Price Rises Above $94,000 -- WSJ

23. Apr. 2025, 09:04 UTC

Top News

Bitcoin Price Rallies. Why Trump, Fed and China Are Boosting the Crypto. -- Barrons.com

23. Apr. 2025, 08:37 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23. Apr. 2025, 08:37 UTC

Market Talk

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Trade War -- Market Talk

23. Apr. 2025, 01:00 UTC

Top News

'I Could Lose It All Tomorrow': The Traders Leaning In to Wild Markets -- WSJ

22. Apr. 2025, 13:58 UTC

Market Talk

Fed Independence Concerns Could Lift Bitcoin to Record High -- Market Talk

22. Apr. 2025, 08:47 UTC

Market Talk

Bitcoin Rises as Investors Seek Dollar Alternatives -- Market Talk

21. Apr. 2025, 14:28 UTC

Top News

Bitcoin Rises. Tariffs, the Dollar, and What Else Is Boosting Crypto Prices. -- Barrons.com

21. Apr. 2025, 14:01 UTC

Akquisitionen, Fusionen, Übernahmen

MicroStrategy Stock Is Rising on Latest $556 Million Bitcoin Purchase -- Barrons.com

21. Apr. 2025, 09:30 UTC

Top News

Crypto Knocks on the Door of a Banking World That Shut It Out -- WSJ

21. Apr. 2025, 09:04 UTC

Top News

Bitcoin and Other Crypto Prices Rise. It's All Linked to Dollar Weakness. -- Barrons.com

17. Apr. 2025, 14:03 UTC

Market Talk

ECB's Lagarde Welcomes Review of Stablecoin Regulation -- Market Talk

17. Apr. 2025, 14:01 UTC

Market Talk

ECB's Lagarde Highlights Digital Euro Efforts -- Market Talk

17. Apr. 2025, 09:48 UTC

Market Talk

Bitcoin Struggles to Rise Meaningfully After Trade News, Powell Remarks -- Market Talk

16. Apr. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

16. Apr. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

16. Apr. 2025, 16:09 UTC

Market Talk

Crypto Trading Demand Lower Than Expected, Interactive Brokers CEO Says -- Market Talk

15. Apr. 2025, 08:33 UTC

Market Talk

Bitcoin Edges Higher Amid Optimism Over Tariff Exemptions -- Market Talk

14. Apr. 2025, 15:52 UTC

Akquisitionen, Fusionen, Übernahmen

MicroStrategy Stock Rises. It Expands Bitcoin Holdings With $286 Million Purchase. -- Barrons.com

Peer-Vergleich

Kursveränderung

NeoGenomics Inc Prognose

Kursziel

By TipRanks

68.3% Vorteil

12-Monats-Prognose

Durchschnitt 16.78 USD  68.3%

Hoch 19 USD

Tief 12 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für NeoGenomics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

14 ratings

10

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

9.56 / 10.27Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.